Zacks Investment Research on MSN3d
ESPR to Study Bempedoic Acid in Pediatric Familial HypercholesterolemiaEsperion Therapeutics ESPR announced that it has come to an alignment with the FDA for initiating two phase III studies. The ...
% differences compared with placebo or indicated statin are based on differences of individual least square means for LDL-C, HDL-C, non-HDL-C and apoB, and on differences of individual medians or ...
Dosing a statin (rosuvastatin) every other day (EOD) may provide significant lipoprotein changes while avoiding common adverse effects in this statin-intolerant population. Objective: To determine ...
Health Digest on MSN3mon
One Of The Safest Cholesterol Medications Still Has A Few Unwanted Side EffectsDr. Pinkey Patel, a clinical pharmacist and CEO/Founder of Myri Health, told Health Digest that drugs like atorvastatin or ...
Ezetimibe is a nonstatin low-density lipoprotein cholesterol-lowering small molecule drug. Ezetimibe is the only currently FDA-approved approved member of the of intestinal cholesterol reuptake ...
Ezetimibe reduces LDL cholesterol levels, and niacin raises HDL cholesterol levels; however, no previous studies have described the use of these two drugs in combination. Jelesoff and colleagues ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback